Use of a novel vitamin D bioavailability test demonstrates that vitamin D absorption is decreased in patients with quiescent Crohn's disease.
about
Association Between Inflammatory Bowel Disease and Vitamin D DeficiencyVitamin D improves inflammatory bowel disease outcomes: basic science and clinical reviewEnvironmental triggers for inflammatory bowel diseaseLinking vitamin d deficiency to inflammatory bowel diseaseReview article: vitamin D and inflammatory bowel disease--established concepts and future directionsVitamin D and inflammatory bowel diseaseVitamin D and the Pathogenesis of Inflammatory Bowel Disease.Delays in puberty, growth, and accrual of bone mineral density in pediatric Crohn's disease: despite temporal changes in disease severity, the need for monitoring remains.Evaluation of vitamin D3 intakes up to 15,000 international units/day and serum 25-hydroxyvitamin D concentrations up to 300 nmol/L on calcium metabolism in a community setting.Vitamin D Status and Bone Mineral Density in Children with Inflammatory Bowel Disease Compared to Those with Functional Abdominal Pain.Escherichia coli-host macrophage interactions in the pathogenesis of inflammatory bowel disease.Maintenance of optimal vitamin D status in children and adolescents with inflammatory bowel disease: a randomized clinical trial comparing two regimens.Vitamin D bioavailability: state of the art.Vitamin D deficiency in patients with intestinal malabsorption syndromes--think in and outside the gut.Probiotics, nuclear receptor signaling, and anti-inflammatory pathways.Treatment of vitamin D insufficiency in children and adolescents with inflammatory bowel disease: a randomized clinical trial comparing three regimens.Common Genetic Variants Influence Circulating Vitamin D Levels in Inflammatory Bowel Diseases.The effect of ultraviolet radiation from a novel portable fluorescent lamp on serum 25-hydroxyvitamin D3 levels in healthy adults with Fitzpatrick skin types II and III.Changes in circulating 25-hydroxyvitamin D according to vitamin D binding protein genotypes after vitamin D₃ or D₂supplementation.Association of Vitamin D Status and Clinical Outcome in Dogs with a Chronic EnteropathyDynamics of vitamin D in patients with mild or inactive inflammatory bowel disease and their families.Review article: vitamin D and inflammatory bowel diseases.Predictors of vitamin D deficiency in inflammatory bowel disease and health: A Mississippi perspective.Vitamin D and Crohn's disease in the adult patient: a review.Optimal vitamin D levels in Crohn's disease: a review.Vitamin D therapy in inflammatory bowel diseases: who, in what form, and how much?Factors associated with vitamin D deficiency in a multicultural inflammatory bowel disease cohort.Role of Vitamin D in Inflammatory Bowel Disease.A Prospective, Randomized, Double-Blind, Parallel-Group, Comparative Effectiveness Clinical Trial Comparing a Powder Vehicle Compound of Vitamin D With an Oil Vehicle Compound in Adults With Cystic Fibrosis.Intestinal absorption of vitamin D: a systematic review.Factors influencing the absorption of vitamin D in GIT: an overview.Vitamin D regulates the tight-junction protein expression in active ulcerative colitis.Vitamin D deficiency in Crohn's disease: prevalence, risk factors and supplement use in an outpatient setting.Vitamin D status in patients with chronic plaque psoriasis
P2860
Q22242722-C0C44CEB-F938-411D-937B-8C700F41B246Q26823927-135F53D4-B0B0-479C-877F-561A674691E7Q26851877-7F6A4AAD-7181-441B-8519-93878C9A6D1DQ27014858-F10E058B-FEC0-4567-B08A-18A07A88368DQ27015639-58AC6DDC-719D-4D22-BE08-A30059F0C3AEQ28085484-0296468F-043E-4108-9B37-E90235B6C734Q30248412-E8CD925F-F98A-49C2-8B6A-8709DA1D6D70Q30412194-CE57F50E-69A9-4DCC-9C6A-A3853DF9CA9AQ33595839-9463B515-4C6F-4BDA-B3C5-FA8C4D6EDA24Q33661372-7B0B6E5E-0DBC-47C5-A203-3600D1DA526EQ33958858-1E9384FF-7AB1-42C9-8663-7D647FD180A3Q34130897-95E72AE9-3C88-4544-8F83-5A3EC90D94EEQ34423940-B14D9C26-6775-4840-B683-2F673B583C8EQ34491388-B6C50BC4-5BD5-4F50-A7EF-EBBBA749D1C1Q35131051-0E2756D2-EBD1-45F7-895D-573C83FCFEB3Q36069892-05C952FA-9305-4B72-8DAD-50DCADDB33F2Q36190018-1FAC950F-F118-49F6-AC13-4FF48279C7EBQ36378730-5E3967AE-15B2-4C21-8AAD-43B62EDCB22DQ36797788-DA96F111-5DAE-4446-86E9-17A6E5BD965EQ36975601-4D8E50D5-DFD2-4572-B055-3568D1734792Q37309420-6B932BEB-CC46-4CD2-9EA2-B0AF8E50C624Q37413426-E22A4161-35D5-4020-8D67-5ABC1559ECEDQ37625213-65DA5E4E-92EE-4131-8068-FCBA77675600Q38155096-6E2E64C7-CE63-4EA5-B698-E61CC1EC3250Q38286526-ECEC95C4-3BD9-4794-A690-5177ACCC8792Q38516988-3D62326C-4240-4323-B51F-FB4A21243A4FQ38609172-423EA253-605D-425F-AB7E-7574B0961BFAQ38767576-528C3019-762B-49CC-8E94-0123FC7E0F0EQ41442798-AC1974B5-7C57-4C4B-9220-523A1CC51CC8Q47810147-4EC2E98A-98AC-4B9F-8526-448EE4949759Q48100475-DD1632E1-D897-47A2-8528-140F6EEC5B0CQ53097289-0E97093D-E04B-44ED-B97A-B7549993DB2AQ53665843-4F4121EA-D186-40FE-806C-BD93E55BF2CBQ58903542-D7528AEA-1851-40A5-BBB9-EA1192C5520A
P2860
Use of a novel vitamin D bioavailability test demonstrates that vitamin D absorption is decreased in patients with quiescent Crohn's disease.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Use of a novel vitamin D bioav ...... ith quiescent Crohn's disease.
@ast
Use of a novel vitamin D bioav ...... ith quiescent Crohn's disease.
@en
Use of a novel vitamin D bioav ...... ith quiescent Crohn's disease.
@nl
type
label
Use of a novel vitamin D bioav ...... ith quiescent Crohn's disease.
@ast
Use of a novel vitamin D bioav ...... ith quiescent Crohn's disease.
@en
Use of a novel vitamin D bioav ...... ith quiescent Crohn's disease.
@nl
prefLabel
Use of a novel vitamin D bioav ...... ith quiescent Crohn's disease.
@ast
Use of a novel vitamin D bioav ...... ith quiescent Crohn's disease.
@en
Use of a novel vitamin D bioav ...... ith quiescent Crohn's disease.
@nl
P2093
P2860
P921
P356
P1476
Use of a novel vitamin D bioav ...... ith quiescent Crohn's disease.
@en
P2093
A B Boulanger
A Tanennbaum
A Vijjeswarapu
F A Farraye
H Nimitphong
K Dendrinos
R Biancuzzo
P2860
P304
P356
10.1002/IBD.21595
P577
2011-01-06T00:00:00Z